1	IL-10	_	NN	_	_	2	NMOD	_	_
2	expression	_	NN	_	_	12	VMOD	_	_
3	by	_	IN	_	_	2	NMOD	_	_
4	cells	_	NNS	_	_	3	PMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	the	_	DT	_	_	11	NMOD	_	_
7	innate	_	JJ	_	_	11	NMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	adaptive	_	JJ	_	_	8	CONJ	_	_
10	immune	_	JJ	_	_	11	NMOD	_	_
11	systems	_	NNS	_	_	5	PMOD	_	_
12	reflects	_	VBZ	_	_	0	ROOT	_	_
13	the	_	DT	_	_	14	NMOD	_	_
14	importance	_	NN	_	_	12	VMOD	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	this	_	DT	_	_	17	NMOD	_	_
17	cytokine	_	NN	_	_	15	PMOD	_	_
18	in	_	IN	_	_	14	NMOD	_	_
19	the	_	DT	_	_	21	NMOD	_	_
20	tight	_	JJ	_	_	21	NMOD	_	_
21	regulation	_	NN	_	_	18	PMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	the	_	DT	_	_	25	NMOD	_	_
24	immune	_	JJ	_	_	25	NMOD	_	_
25	response	_	NN	_	_	22	PMOD	_	_
26	,	_	,	_	_	12	P	_	_
27	to	_	TO	_	_	12	VMOD	_	_
28	minimize	_	VB	_	_	27	IM	_	_
29	pathology	_	NN	_	_	28	VMOD	_	_
30	during	_	IN	_	_	28	VMOD	_	_
31	infection	_	NN	_	_	30	PMOD	_	_
32	.	_	.	_	_	12	P	_	_
		
1	IL-10	_	NN	_	_	2	NMOD	_	_
2	expression	_	NN	_	_	6	VMOD	_	_
3	by	_	IN	_	_	2	NMOD	_	_
4	Th1	_	NN	_	_	5	NMOD	_	_
5	cells	_	NNS	_	_	3	PMOD	_	_
6	has	_	VBZ	_	_	0	ROOT	_	_
7	been	_	VBN	_	_	6	VC	_	_
8	reported	_	VBN	_	_	7	VC	_	_
9	to	_	TO	_	_	8	VMOD	_	_
10	regulate	_	VB	_	_	9	IM	_	_
11	the	_	DT	_	_	13	NMOD	_	_
12	immune	_	JJ	_	_	13	NMOD	_	_
13	response	_	NN	_	_	10	VMOD	_	_
14	in	_	IN	_	_	13	NMOD	_	_
15	leishmaniasis	_	NN	_	_	14	PMOD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	toxoplasmosis	_	NN	_	_	16	CONJ	_	_
18	.	_	.	_	_	6	P	_	_
		
1	However	_	RB	_	_	8	VMOD	_	_
2	,	_	,	_	_	8	P	_	_
3	in	_	IN	_	_	8	VMOD	_	_
4	many	_	JJ	_	_	5	NMOD	_	_
5	situations	_	NNS	_	_	3	PMOD	_	_
6	,	_	,	_	_	8	P	_	_
7	IL-10	_	NN	_	_	8	VMOD	_	_
8	is	_	VBZ	_	_	0	ROOT	_	_
9	not	_	RB	_	_	8	VMOD	_	_
10	produced	_	VBN	_	_	8	VC	_	_
11	by	_	IN	_	_	10	VMOD	_	_
12	Th1	_	NN	_	_	13	NMOD	_	_
13	cells	_	NNS	_	_	11	PMOD	_	_
14	in	_	IN	_	_	10	VMOD	_	_
15	response	_	NN	_	_	14	PMOD	_	_
16	to	_	TO	_	_	15	NMOD	_	_
17	antigenic	_	JJ	_	_	18	NMOD	_	_
18	stimulation	_	NN	_	_	16	PMOD	_	_
19	.	_	.	_	_	8	P	_	_
		
1	Our	_	PRP$	_	_	2	NMOD	_	_
2	goal	_	NN	_	_	3	VMOD	_	_
3	was	_	VBD	_	_	0	ROOT	_	_
4	to	_	TO	_	_	3	VC	_	_
5	address	_	VB	_	_	4	IM	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	molecular	_	JJ	_	_	8	NMOD	_	_
8	signals	_	NNS	_	_	5	VMOD	_	_
9	that	_	WDT	_	_	10	VMOD	_	_
10	determine	_	VBP	_	_	8	NMOD	_	_
11	whether	_	IN	_	_	10	VMOD	_	_
12	Th1	_	NN	_	_	13	NMOD	_	_
13	cells	_	NNS	_	_	14	VMOD	_	_
14	develop	_	VBP	_	_	11	SUB	_	_
15	to	_	TO	_	_	14	VMOD	_	_
16	produce	_	VB	_	_	15	IM	_	_
17	IL-10	_	NN	_	_	16	VMOD	_	_
18	(	_	(	_	_	19	P	_	_
19	Trinchieri	_	NNP	_	_	5	PRN	_	_
20	,	_	,	_	_	19	P	_	_
21	2007	_	CD	_	_	19	APPO	_	_
22	)	_	)	_	_	19	P	_	_
23	.	_	.	_	_	3	P	_	_
		
1	Here	_	RB	_	_	4	VMOD	_	_
2	,	_	,	_	_	4	P	_	_
3	we	_	PRP	_	_	4	VMOD	_	_
4	showed	_	VBD	_	_	0	ROOT	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	Th1	_	NN	_	_	7	NMOD	_	_
7	cells	_	NNS	_	_	8	VMOD	_	_
8	required	_	VBD	_	_	5	SUB	_	_
9	high-antigen-dose-induced	_	JJ	_	_	13	NMOD	_	_
10	ERK1	_	NN	_	_	13	NMOD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	ERK2	_	NN	_	_	11	CONJ	_	_
13	phosphorylation	_	NN	_	_	8	VMOD	_	_
14	and	_	CC	_	_	13	COORD	_	_
15	IL-12-induced	_	JJ	_	_	17	NMOD	_	_
16	STAT-4	_	NN	_	_	17	NMOD	_	_
17	activation	_	NN	_	_	14	CONJ	_	_
18	to	_	TO	_	_	8	VMOD	_	_
19	produce	_	VB	_	_	18	IM	_	_
20	IL-10	_	NN	_	_	19	VMOD	_	_
21	.	_	.	_	_	4	P	_	_
		
1	Our	_	PRP$	_	_	2	NMOD	_	_
2	findings	_	NNS	_	_	8	VMOD	_	_
3	that	_	IN	_	_	2	NMOD	_	_
4	ERK1	_	NN	_	_	7	NMOD	_	_
5	and	_	CC	_	_	4	COORD	_	_
6	ERK2	_	NN	_	_	5	CONJ	_	_
7	activation	_	NN	_	_	3	PMOD	_	_
8	was	_	VBD	_	_	0	ROOT	_	_
9	a	_	DT	_	_	11	NMOD	_	_
10	common	_	JJ	_	_	11	NMOD	_	_
11	pathway	_	NN	_	_	8	VMOD	_	_
12	required	_	VBN	_	_	11	APPO	_	_
13	for	_	IN	_	_	12	VMOD	_	_
14	the	_	DT	_	_	15	NMOD	_	_
15	production	_	NN	_	_	13	PMOD	_	_
16	of	_	IN	_	_	15	NMOD	_	_
17	IL-10	_	NN	_	_	16	PMOD	_	_
18	by	_	IN	_	_	15	NMOD	_	_
19	Th1	_	NN	_	_	26	NMOD	_	_
20	,	_	,	_	_	19	P	_	_
21	Th2	_	NN	_	_	19	COORD	_	_
22	,	_	,	_	_	21	P	_	_
23	and	_	CC	_	_	21	COORD	_	_
24	Th17	_	NN	_	_	23	CONJ	_	_
25	cell	_	NN	_	_	26	NMOD	_	_
26	subsets	_	NNS	_	_	18	PMOD	_	_
27	,	_	,	_	_	11	P	_	_
28	which	_	WDT	_	_	29	VMOD	_	_
29	differentiate	_	VBP	_	_	11	NMOD	_	_
30	along	_	IN	_	_	29	VMOD	_	_
31	distinct	_	JJ	_	_	32	NMOD	_	_
32	pathways	_	NNS	_	_	30	PMOD	_	_
33	,	_	,	_	_	29	P	_	_
34	such	_	JJ	_	_	35	DEP	_	_
35	that	_	IN	_	_	29	VMOD	_	_
36	IL-10	_	NN	_	_	37	VMOD	_	_
37	provides	_	VBZ	_	_	35	SUB	_	_
38	a	_	DT	_	_	42	NMOD	_	_
39	highly	_	RB	_	_	40	AMOD	_	_
40	regulated	_	VBN	_	_	42	NMOD	_	_
41	feedback	_	NN	_	_	42	NMOD	_	_
42	loop	_	NN	_	_	37	VMOD	_	_
43	to	_	TO	_	_	42	NMOD	_	_
44	avoid	_	VB	_	_	43	IM	_	_
45	the	_	DT	_	_	46	NMOD	_	_
46	extremes	_	NNS	_	_	44	VMOD	_	_
47	of	_	IN	_	_	46	NMOD	_	_
48	excessive	_	JJ	_	_	49	NMOD	_	_
49	inflammation	_	NN	_	_	47	PMOD	_	_
50	or	_	CC	_	_	49	COORD	_	_
51	chronic	_	JJ	_	_	52	NMOD	_	_
52	infections	_	NNS	_	_	50	CONJ	_	_
53	and	_	CC	_	_	44	COORD	_	_
54	also	_	RB	_	_	44	VMOD	_	_
55	allow	_	VB	_	_	53	CONJ	_	_
56	a	_	DT	_	_	58	NMOD	_	_
57	protective	_	JJ	_	_	58	NMOD	_	_
58	response	_	NN	_	_	55	VMOD	_	_
59	to	_	TO	_	_	58	NMOD	_	_
60	diverse	_	JJ	_	_	61	NMOD	_	_
61	pathogens	_	NNS	_	_	59	PMOD	_	_
62	.	_	.	_	_	8	P	_	_
		
1	In	_	IN	_	_	31	VMOD	_	_
2	certain	_	JJ	_	_	6	NMOD	_	_
3	viral	_	JJ	_	_	6	NMOD	_	_
4	or	_	CC	_	_	3	COORD	_	_
5	parasitic	_	JJ	_	_	4	CONJ	_	_
6	infections	_	NNS	_	_	1	PMOD	_	_
7	(	_	(	_	_	8	P	_	_
8	Anderson	_	NNP	_	_	6	PRN	_	_
9	et	_	FW	_	_	8	NMOD	_	_
10	al.	_	FW	_	_	8	NMOD	_	_
11	,	_	,	_	_	8	P	_	_
12	2007	_	CD	_	_	8	NMOD	_	_
13	;	_	:	_	_	8	P	_	_
14	Brooks	_	NN	_	_	8	COORD	_	_
15	et	_	FW	_	_	14	NMOD	_	_
16	al.	_	FW	_	_	15	AMOD	_	_
17	,	_	,	_	_	14	P	_	_
18	2006	_	NN	_	_	14	COORD	_	_
19	;	_	:	_	_	18	P	_	_
20	Ejrnaes	_	NNP	_	_	18	COORD	_	_
21	et	_	FW	_	_	20	NMOD	_	_
22	al.	_	FW	_	_	20	NMOD	_	_
23	,	_	,	_	_	20	P	_	_
24	2006	_	NN	_	_	20	COORD	_	_
25	)	_	)	_	_	8	P	_	_
26	,	_	,	_	_	31	P	_	_
27	high	_	JJ	_	_	28	NMOD	_	_
28	amounts	_	NNS	_	_	31	VMOD	_	_
29	of	_	IN	_	_	28	NMOD	_	_
30	stimulation	_	NN	_	_	29	PMOD	_	_
31	may	_	MD	_	_	0	ROOT	_	_
32	lead	_	VB	_	_	31	VC	_	_
33	to	_	TO	_	_	32	VMOD	_	_
34	the	_	DT	_	_	37	NMOD	_	_
35	chronic	_	JJ	_	_	37	NMOD	_	_
36	nonhealing	_	JJ	_	_	37	NMOD	_	_
37	infection	_	NN	_	_	33	PMOD	_	_
38	shown	_	VBN	_	_	37	APPO	_	_
39	to	_	TO	_	_	38	VMOD	_	_
40	be	_	VB	_	_	39	IM	_	_
41	regulated	_	VBN	_	_	40	VC	_	_
42	by	_	IN	_	_	41	VMOD	_	_
43	IL-10	_	NN	_	_	42	PMOD	_	_
44	.	_	.	_	_	31	P	_	_
		
1	During	_	IN	_	_	15	VMOD	_	_
2	the	_	DT	_	_	3	NMOD	_	_
3	course	_	NN	_	_	1	PMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	infection	_	NN	_	_	4	PMOD	_	_
6	,	_	,	_	_	15	P	_	_
7	after	_	IN	_	_	15	VMOD	_	_
8	initial	_	JJ	_	_	9	NMOD	_	_
9	triggering	_	NN	_	_	7	PMOD	_	_
10	with	_	IN	_	_	9	NMOD	_	_
11	antigen	_	NN	_	_	10	PMOD	_	_
12	,	_	,	_	_	15	P	_	_
13	T	_	NN	_	_	14	NMOD	_	_
14	cells	_	NNS	_	_	15	VMOD	_	_
15	migrate	_	VBP	_	_	0	ROOT	_	_
16	to	_	TO	_	_	15	VMOD	_	_
17	the	_	DT	_	_	18	NMOD	_	_
18	tissue	_	NN	_	_	16	PMOD	_	_
19	encountering	_	VBG	_	_	18	APPO	_	_
20	high	_	JJ	_	_	21	NMOD	_	_
21	doses	_	NNS	_	_	19	VMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	antigen	_	NN	_	_	22	PMOD	_	_
24	and	_	CC	_	_	23	COORD	_	_
25	factors	_	NNS	_	_	24	CONJ	_	_
26	produced	_	VBN	_	_	25	APPO	_	_
27	by	_	IN	_	_	26	VMOD	_	_
28	the	_	DT	_	_	31	NMOD	_	_
29	innate	_	JJ	_	_	31	NMOD	_	_
30	immune	_	JJ	_	_	31	NMOD	_	_
31	response	_	NN	_	_	27	PMOD	_	_
32	.	_	.	_	_	15	P	_	_
		
1	Under	_	IN	_	_	6	VMOD	_	_
2	these	_	DT	_	_	3	NMOD	_	_
3	conditions	_	NNS	_	_	1	PMOD	_	_
4	,	_	,	_	_	6	P	_	_
5	we	_	PRP	_	_	6	VMOD	_	_
6	speculate	_	VBP	_	_	0	ROOT	_	_
7	that	_	IN	_	_	6	VMOD	_	_
8	Th1	_	NN	_	_	9	NMOD	_	_
9	cells	_	NNS	_	_	10	VMOD	_	_
10	will	_	MD	_	_	7	SUB	_	_
11	be	_	VB	_	_	10	VC	_	_
12	induced	_	VBN	_	_	11	VC	_	_
13	to	_	TO	_	_	12	VMOD	_	_
14	express	_	VB	_	_	13	IM	_	_
15	high	_	JJ	_	_	16	NMOD	_	_
16	amounts	_	NNS	_	_	14	VMOD	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	IL-10	_	NN	_	_	17	PMOD	_	_
19	,	_	,	_	_	14	P	_	_
20	in	_	IN	_	_	14	VMOD	_	_
21	keeping	_	VBG	_	_	20	PMOD	_	_
22	with	_	IN	_	_	21	VMOD	_	_
23	reports	_	NNS	_	_	22	PMOD	_	_
24	that	_	IN	_	_	23	NMOD	_	_
25	IL-10-producing	_	JJ	_	_	27	NMOD	_	_
26	Th1	_	NN	_	_	27	NMOD	_	_
27	cells	_	NNS	_	_	28	VMOD	_	_
28	were	_	VBD	_	_	24	SUB	_	_
29	found	_	VBN	_	_	28	VC	_	_
30	in	_	IN	_	_	29	VMOD	_	_
31	CD4+	_	JJ	_	_	32	NMOD	_	_
32	clones	_	NNS	_	_	30	PMOD	_	_
33	isolated	_	VBN	_	_	32	APPO	_	_
34	from	_	IN	_	_	33	VMOD	_	_
35	BAL	_	NN	_	_	34	PMOD	_	_
36	but	_	CC	_	_	35	COORD	_	_
37	not	_	RB	_	_	36	COORD	_	_
38	blood	_	NN	_	_	36	CONJ	_	_
39	of	_	IN	_	_	35	NMOD	_	_
40	TB	_	JJ	_	_	41	NMOD	_	_
41	patients	_	NNS	_	_	39	PMOD	_	_
42	(	_	(	_	_	43	P	_	_
43	Gerosa	_	NNP	_	_	29	PRN	_	_
44	et	_	FW	_	_	43	NMOD	_	_
45	al.	_	FW	_	_	43	NMOD	_	_
46	,	_	,	_	_	43	P	_	_
47	1999	_	CD	_	_	43	APPO	_	_
48	)	_	)	_	_	43	P	_	_
49	.	_	.	_	_	6	P	_	_
		
1	Similarly	_	RB	_	_	21	VMOD	_	_
2	,	_	,	_	_	21	P	_	_
3	the	_	DT	_	_	5	NMOD	_	_
4	immune	_	JJ	_	_	5	NMOD	_	_
5	response	_	NN	_	_	21	VMOD	_	_
6	to	_	TO	_	_	5	NMOD	_	_
7	a	_	DT	_	_	9	NMOD	_	_
8	clinical	_	JJ	_	_	9	NMOD	_	_
9	isolate	_	NN	_	_	6	PMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	L.	_	FW	_	_	12	NMOD	_	_
12	major	_	JJ	_	_	10	PMOD	_	_
13	,	_	,	_	_	5	P	_	_
14	which	_	WDT	_	_	15	VMOD	_	_
15	produces	_	VBZ	_	_	5	NMOD	_	_
16	heavily	_	RB	_	_	17	AMOD	_	_
17	infected	_	JJ	_	_	19	NMOD	_	_
18	nonhealing	_	JJ	_	_	19	NMOD	_	_
19	lesions	_	NNS	_	_	15	VMOD	_	_
20	,	_	,	_	_	5	P	_	_
21	was	_	VBD	_	_	0	ROOT	_	_
22	found	_	VBN	_	_	21	VC	_	_
23	to	_	TO	_	_	22	VMOD	_	_
24	be	_	VB	_	_	23	IM	_	_
25	regulated	_	VBN	_	_	24	VC	_	_
26	by	_	IN	_	_	25	VMOD	_	_
27	IL-10	_	NN	_	_	26	PMOD	_	_
28	derived	_	VBN	_	_	27	APPO	_	_
29	from	_	IN	_	_	28	VMOD	_	_
30	Foxp3-	_	JJ	_	_	32	NMOD	_	_
31	Th1	_	NN	_	_	32	NMOD	_	_
32	cells	_	NNS	_	_	29	PMOD	_	_
33	that	_	WDT	_	_	34	VMOD	_	_
34	coproduce	_	VBP	_	_	32	NMOD	_	_
35	IL-10	_	NN	_	_	34	VMOD	_	_
36	and	_	CC	_	_	35	COORD	_	_
37	IFN-gamma	_	NN	_	_	36	CONJ	_	_
38	(	_	(	_	_	39	P	_	_
39	Anderson	_	NNP	_	_	37	PRN	_	_
40	et	_	FW	_	_	39	NMOD	_	_
41	al.	_	FW	_	_	39	NMOD	_	_
42	,	_	,	_	_	39	P	_	_
43	2007	_	CD	_	_	39	NMOD	_	_
44	)	_	)	_	_	39	P	_	_
45	,	_	,	_	_	21	P	_	_
46	and	_	CC	_	_	21	COORD	_	_
47	the	_	DT	_	_	49	NMOD	_	_
48	immune	_	JJ	_	_	49	NMOD	_	_
49	response	_	NN	_	_	54	VMOD	_	_
50	during	_	IN	_	_	49	NMOD	_	_
51	T.	_	FW	_	_	53	NMOD	_	_
52	gondii	_	FW	_	_	53	NMOD	_	_
53	infection	_	NN	_	_	50	PMOD	_	_
54	was	_	VBD	_	_	46	CONJ	_	_
55	found	_	VBN	_	_	54	VC	_	_
56	also	_	RB	_	_	57	VMOD	_	_
57	to	_	TO	_	_	55	VMOD	_	_
58	be	_	VB	_	_	57	IM	_	_
59	regulated	_	VBN	_	_	58	VC	_	_
60	by	_	IN	_	_	59	VMOD	_	_
61	Foxp3-	_	JJ	_	_	63	NMOD	_	_
62	Th1	_	NN	_	_	63	NMOD	_	_
63	cells	_	NNS	_	_	60	PMOD	_	_
64	(	_	(	_	_	65	P	_	_
65	Jankovic	_	NNP	_	_	63	PRN	_	_
66	et	_	FW	_	_	65	NMOD	_	_
67	al.	_	FW	_	_	65	NMOD	_	_
68	,	_	,	_	_	65	P	_	_
69	2007	_	CD	_	_	65	NMOD	_	_
70	)	_	)	_	_	65	P	_	_
71	.	_	.	_	_	21	P	_	_
		
1	It	_	PRP	_	_	2	VMOD	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	likely	_	JJ	_	_	2	VMOD	_	_
4	that	_	IN	_	_	3	AMOD	_	_
5	IL-10	_	NN	_	_	6	NMOD	_	_
6	production	_	NN	_	_	10	VMOD	_	_
7	by	_	IN	_	_	6	NMOD	_	_
8	Th1	_	NN	_	_	9	NMOD	_	_
9	cells	_	NNS	_	_	7	PMOD	_	_
10	is	_	VBZ	_	_	4	SUB	_	_
11	evoked	_	VBN	_	_	10	VC	_	_
12	under	_	IN	_	_	11	VMOD	_	_
13	conditions	_	NNS	_	_	12	PMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	high	_	JJ	_	_	16	NMOD	_	_
16	inflammation	_	NN	_	_	14	PMOD	_	_
17	and	_	CC	_	_	16	COORD	_	_
18	antigenic	_	JJ	_	_	19	NMOD	_	_
19	stimulation	_	NN	_	_	17	CONJ	_	_
20	,	_	,	_	_	10	P	_	_
21	whereas	_	IN	_	_	10	COORD	_	_
22	regulatory	_	JJ	_	_	25	NMOD	_	_
23	CD4+	_	JJ	_	_	25	NMOD	_	_
24	T	_	NN	_	_	25	NMOD	_	_
25	cells	_	NNS	_	_	28	VMOD	_	_
26	producing	_	VBG	_	_	25	APPO	_	_
27	IL-10	_	NN	_	_	26	VMOD	_	_
28	may	_	MD	_	_	21	COORD	_	_
29	operate	_	VB	_	_	28	VC	_	_
30	to	_	TO	_	_	29	VMOD	_	_
31	regulate	_	VB	_	_	30	IM	_	_
32	the	_	DT	_	_	34	NMOD	_	_
33	immune	_	JJ	_	_	34	NMOD	_	_
34	response	_	NN	_	_	31	VMOD	_	_
35	under	_	IN	_	_	31	VMOD	_	_
36	conditions	_	NNS	_	_	35	PMOD	_	_
37	in	_	IN	_	_	41	VMOD	_	_
38	which	_	WDT	_	_	37	PMOD	_	_
39	the	_	DT	_	_	40	NMOD	_	_
40	pathogen	_	NN	_	_	41	VMOD	_	_
41	is	_	VBZ	_	_	36	NMOD	_	_
42	clinically	_	RB	_	_	41	VMOD	_	_
43	controlled	_	VBN	_	_	41	VC	_	_
44	,	_	,	_	_	36	P	_	_
45	such	_	JJ	_	_	46	DEP	_	_
46	as	_	IN	_	_	36	NMOD	_	_
47	in	_	IN	_	_	46	PMOD	_	_
48	infection	_	NN	_	_	47	PMOD	_	_
49	with	_	IN	_	_	48	NMOD	_	_
50	L.	_	FW	_	_	51	NMOD	_	_
51	major	_	JJ	_	_	49	PMOD	_	_
52	(	_	(	_	_	54	P	_	_
53	Friedlin	_	NN	_	_	54	NMOD	_	_
54	strain	_	NN	_	_	51	PRN	_	_
55	)	_	)	_	_	54	P	_	_
56	(	_	(	_	_	57	P	_	_
57	Belkaid	_	NNP	_	_	51	PRN	_	_
58	et	_	FW	_	_	57	NMOD	_	_
59	al.	_	FW	_	_	57	NMOD	_	_
60	,	_	,	_	_	57	P	_	_
61	2002	_	CD	_	_	57	NMOD	_	_
62	;	_	:	_	_	57	P	_	_
63	Suffia	_	NNP	_	_	57	APPO	_	_
64	et	_	FW	_	_	63	NMOD	_	_
65	al.	_	FW	_	_	63	NMOD	_	_
66	,	_	,	_	_	63	P	_	_
67	2006	_	NN	_	_	63	NMOD	_	_
68	)	_	)	_	_	57	P	_	_
69	.	_	.	_	_	2	P	_	_
		
1	We	_	PRP	_	_	4	VMOD	_	_
2	now	_	RB	_	_	4	VMOD	_	_
3	also	_	RB	_	_	4	VMOD	_	_
4	reported	_	VBD	_	_	0	ROOT	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	CD4+	_	JJ	_	_	8	NMOD	_	_
7	T	_	NN	_	_	8	NMOD	_	_
8	cells	_	NNS	_	_	16	VMOD	_	_
9	cultured	_	VBN	_	_	8	APPO	_	_
10	with	_	IN	_	_	9	VMOD	_	_
11	high	_	JJ	_	_	13	NMOD	_	_
12	antigen	_	NN	_	_	13	NMOD	_	_
13	dose	_	NN	_	_	10	PMOD	_	_
14	and	_	CC	_	_	13	COORD	_	_
15	IL-12	_	NN	_	_	14	CONJ	_	_
16	differentiate	_	VBP	_	_	5	SUB	_	_
17	into	_	IN	_	_	16	VMOD	_	_
18	canonical	_	JJ	_	_	21	NMOD	_	_
19	Th1	_	NN	_	_	21	NMOD	_	_
20	effector	_	NN	_	_	21	NMOD	_	_
21	cells	_	NNS	_	_	17	PMOD	_	_
22	,	_	,	_	_	21	P	_	_
23	which	_	WDT	_	_	36	VMOD	_	_
24	,	_	,	_	_	36	P	_	_
25	in	_	IN	_	_	36	VMOD	_	_
26	addition	_	NN	_	_	25	DEP	_	_
27	to	_	TO	_	_	25	DEP	_	_
28	expressing	_	VBG	_	_	25	PMOD	_	_
29	large	_	JJ	_	_	30	NMOD	_	_
30	amounts	_	NNS	_	_	28	VMOD	_	_
31	of	_	IN	_	_	30	NMOD	_	_
32	IFN-gamma	_	NN	_	_	31	PMOD	_	_
33	and	_	CC	_	_	32	COORD	_	_
34	IL-10	_	NN	_	_	33	CONJ	_	_
35	,	_	,	_	_	36	P	_	_
36	lose	_	VB	_	_	21	NMOD	_	_
37	their	_	PRP$	_	_	39	NMOD	_	_
38	IL-2	_	NN	_	_	39	NMOD	_	_
39	expression	_	NN	_	_	36	VMOD	_	_
40	as	_	IN	_	_	36	VMOD	_	_
41	described	_	VBN	_	_	40	SUB	_	_
42	before	_	IN	_	_	41	PRT	_	_
43	in	_	IN	_	_	41	VMOD	_	_
44	certain	_	JJ	_	_	47	NMOD	_	_
45	chronic	_	JJ	_	_	47	NMOD	_	_
46	infection	_	NN	_	_	47	NMOD	_	_
47	models	_	NNS	_	_	43	PMOD	_	_
48	(	_	(	_	_	49	P	_	_
49	Sallusto	_	NNP	_	_	47	PRN	_	_
50	et	_	FW	_	_	49	NMOD	_	_
51	al.	_	FW	_	_	49	NMOD	_	_
52	,	_	,	_	_	49	P	_	_
53	2004	_	CD	_	_	49	NMOD	_	_
54	)	_	)	_	_	49	P	_	_
55	.	_	.	_	_	4	P	_	_
		
1	Our	_	PRP$	_	_	2	NMOD	_	_
2	demonstration	_	NN	_	_	13	VMOD	_	_
3	that	_	IN	_	_	2	NMOD	_	_
4	loss	_	NN	_	_	7	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	IL-2	_	NN	_	_	5	PMOD	_	_
7	is	_	VBZ	_	_	3	SUB	_	_
8	accompanied	_	VBN	_	_	7	VC	_	_
9	by	_	IN	_	_	8	VMOD	_	_
10	production	_	NN	_	_	9	PMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	IL-10	_	NN	_	_	11	PMOD	_	_
13	offers	_	VBZ	_	_	0	ROOT	_	_
14	potential	_	JJ	_	_	16	NMOD	_	_
15	additional	_	JJ	_	_	16	NMOD	_	_
16	mechanisms	_	NNS	_	_	13	VMOD	_	_
17	whereby	_	WRB	_	_	22	VMOD	_	_
18	effector	_	NN	_	_	21	NMOD	_	_
19	T	_	NN	_	_	21	NMOD	_	_
20	cell	_	NN	_	_	21	NMOD	_	_
21	responses	_	NNS	_	_	22	VMOD	_	_
22	may	_	MD	_	_	16	NMOD	_	_
23	be	_	VB	_	_	22	VC	_	_
24	dampened	_	JJ	_	_	23	VMOD	_	_
25	during	_	IN	_	_	23	VMOD	_	_
26	chronic	_	JJ	_	_	27	NMOD	_	_
27	disease	_	NN	_	_	25	PMOD	_	_
28	.	_	.	_	_	13	P	_	_
		
1	Using	_	VBG	_	_	21	VMOD	_	_
2	an	_	DT	_	_	6	NMOD	_	_
3	in	_	FW	_	_	4	AMOD	_	_
4	vivo	_	FW	_	_	6	NMOD	_	_
5	transfer	_	NN	_	_	6	NMOD	_	_
6	model	_	NN	_	_	1	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	DO11.10	_	NN	_	_	11	NMOD	_	_
9	TCR	_	NN	_	_	11	NMOD	_	_
10	transgenic	_	JJ	_	_	11	NMOD	_	_
11	cells	_	NNS	_	_	7	PMOD	_	_
12	(	_	(	_	_	13	P	_	_
13	Castro	_	NNP	_	_	1	PRN	_	_
14	et	_	FW	_	_	13	NMOD	_	_
15	al.	_	FW	_	_	13	NMOD	_	_
16	,	_	,	_	_	13	P	_	_
17	2000	_	CD	_	_	13	APPO	_	_
18	)	_	)	_	_	13	P	_	_
19	,	_	,	_	_	21	P	_	_
20	we	_	PRP	_	_	21	VMOD	_	_
21	showed	_	VBD	_	_	0	ROOT	_	_
22	that	_	IN	_	_	21	VMOD	_	_
23	IL-10-producing	_	JJ	_	_	25	NMOD	_	_
24	Th1	_	NN	_	_	25	NMOD	_	_
25	cells	_	NNS	_	_	26	VMOD	_	_
26	were	_	VBD	_	_	22	SUB	_	_
27	differentiated	_	VBN	_	_	26	VC	_	_
28	in	_	IN	_	_	27	VMOD	_	_
29	the	_	DT	_	_	30	NMOD	_	_
30	presence	_	NN	_	_	28	PMOD	_	_
31	of	_	IN	_	_	30	NMOD	_	_
32	high	_	JJ	_	_	33	NMOD	_	_
33	doses	_	NNS	_	_	31	PMOD	_	_
34	of	_	IN	_	_	33	NMOD	_	_
35	OVA	_	NN	_	_	36	NMOD	_	_
36	protein	_	NN	_	_	34	PMOD	_	_
37	and	_	CC	_	_	36	COORD	_	_
38	LPS	_	NN	_	_	37	CONJ	_	_
39	.	_	.	_	_	21	P	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	showed	_	VBD	_	_	0	ROOT	_	_
3	here	_	RB	_	_	2	VMOD	_	_
4	that	_	IN	_	_	2	VMOD	_	_
5	this	_	DT	_	_	6	NMOD	_	_
6	induction	_	NN	_	_	14	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	IL-10	_	NN	_	_	7	PMOD	_	_
9	in	_	IN	_	_	6	NMOD	_	_
10	Th1	_	NN	_	_	11	NMOD	_	_
11	cells	_	NNS	_	_	9	PMOD	_	_
12	in	_	FW	_	_	6	NMOD	_	_
13	vivo	_	FW	_	_	12	AMOD	_	_
14	was	_	VBD	_	_	4	SUB	_	_
15	markedly	_	RB	_	_	14	VMOD	_	_
16	,	_	,	_	_	15	P	_	_
17	but	_	CC	_	_	15	COORD	_	_
18	not	_	RB	_	_	17	COORD	_	_
19	totally	_	RB	_	_	17	CONJ	_	_
20	,	_	,	_	_	14	P	_	_
21	reduced	_	VBN	_	_	14	VC	_	_
22	in	_	IN	_	_	21	VMOD	_	_
23	STAT4-deficient	_	JJ	_	_	25	NMOD	_	_
24	T	_	NN	_	_	25	NMOD	_	_
25	cells	_	NNS	_	_	22	PMOD	_	_
26	as	_	IN	_	_	21	VMOD	_	_
27	observed	_	VBN	_	_	26	SUB	_	_
28	during	_	IN	_	_	27	VMOD	_	_
29	T.	_	FW	_	_	30	AMOD	_	_
30	gondii	_	FW	_	_	31	NMOD	_	_
31	infection	_	NN	_	_	28	PMOD	_	_
32	(	_	(	_	_	33	P	_	_
33	Jankovic	_	NNP	_	_	31	PRN	_	_
34	et	_	FW	_	_	33	NMOD	_	_
35	al.	_	FW	_	_	33	NMOD	_	_
36	,	_	,	_	_	33	P	_	_
37	2002	_	CD	_	_	33	NMOD	_	_
38	)	_	)	_	_	33	P	_	_
39	.	_	.	_	_	2	P	_	_
		
1	A	_	DT	_	_	4	NMOD	_	_
2	high	_	JJ	_	_	4	NMOD	_	_
3	antigenic	_	JJ	_	_	4	NMOD	_	_
4	activation	_	NN	_	_	26	VMOD	_	_
5	during	_	IN	_	_	4	NMOD	_	_
6	T.	_	FW	_	_	7	AMOD	_	_
7	gondii	_	FW	_	_	8	NMOD	_	_
8	infection	_	NN	_	_	5	PMOD	_	_
9	or	_	CC	_	_	8	COORD	_	_
10	high	_	JJ	_	_	12	NMOD	_	_
11	antigen	_	NN	_	_	12	NMOD	_	_
12	doses	_	NNS	_	_	9	CONJ	_	_
13	delivered	_	VBN	_	_	12	APPO	_	_
14	in	_	IN	_	_	13	VMOD	_	_
15	the	_	DT	_	_	16	NMOD	_	_
16	presence	_	NN	_	_	14	PMOD	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	LPS	_	NN	_	_	17	PMOD	_	_
19	,	_	,	_	_	4	P	_	_
20	as	_	IN	_	_	4	NMOD	_	_
21	seen	_	VBN	_	_	20	SUB	_	_
22	in	_	IN	_	_	21	VMOD	_	_
23	our	_	PRP$	_	_	24	NMOD	_	_
24	system	_	NN	_	_	22	PMOD	_	_
25	,	_	,	_	_	4	P	_	_
26	may	_	MD	_	_	0	ROOT	_	_
27	compensate	_	VB	_	_	26	VC	_	_
28	for	_	IN	_	_	27	VMOD	_	_
29	an	_	DT	_	_	31	NMOD	_	_
30	absolute	_	JJ	_	_	31	NMOD	_	_
31	requirement	_	NN	_	_	28	PMOD	_	_
32	for	_	IN	_	_	31	NMOD	_	_
33	IL-12	_	NN	_	_	32	PMOD	_	_
34	in	_	IN	_	_	31	NMOD	_	_
35	the	_	DT	_	_	36	NMOD	_	_
36	induction	_	NN	_	_	34	PMOD	_	_
37	of	_	IN	_	_	36	NMOD	_	_
38	IL-10	_	NN	_	_	37	PMOD	_	_
39	by	_	IN	_	_	36	NMOD	_	_
40	Th1	_	NN	_	_	41	NMOD	_	_
41	cells	_	NNS	_	_	39	PMOD	_	_
42	.	_	.	_	_	26	P	_	_
		
1	In	_	IN	_	_	16	VMOD	_	_
2	our	_	PRP$	_	_	5	NMOD	_	_
3	in	_	FW	_	_	4	AMOD	_	_
4	vitro	_	FW	_	_	5	NMOD	_	_
5	system	_	NN	_	_	1	PMOD	_	_
6	,	_	,	_	_	16	P	_	_
7	repeated	_	JJ	_	_	8	NMOD	_	_
8	stimulation	_	NN	_	_	16	VMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	Th1	_	NN	_	_	11	NMOD	_	_
11	cells	_	NNS	_	_	9	PMOD	_	_
12	with	_	IN	_	_	8	NMOD	_	_
13	high	_	JJ	_	_	15	NMOD	_	_
14	antigen	_	NN	_	_	15	NMOD	_	_
15	doses	_	NNS	_	_	12	PMOD	_	_
16	allowed	_	VBD	_	_	0	ROOT	_	_
17	the	_	DT	_	_	18	NMOD	_	_
18	development	_	NN	_	_	16	VMOD	_	_
19	of	_	IN	_	_	18	NMOD	_	_
20	Th1	_	NN	_	_	21	NMOD	_	_
21	cells	_	NNS	_	_	19	PMOD	_	_
22	producing	_	VBG	_	_	21	APPO	_	_
23	IL-10	_	NN	_	_	22	VMOD	_	_
24	in	_	IN	_	_	16	VMOD	_	_
25	an	_	DT	_	_	27	NMOD	_	_
26	IL-12-dependent	_	JJ	_	_	27	NMOD	_	_
27	manner	_	NN	_	_	24	PMOD	_	_
28	.	_	.	_	_	16	P	_	_
		
1	IL-10	_	NN	_	_	2	NMOD	_	_
2	production	_	NN	_	_	13	VMOD	_	_
3	by	_	IN	_	_	2	NMOD	_	_
4	Th1	_	NN	_	_	5	NMOD	_	_
5	cells	_	NNS	_	_	3	PMOD	_	_
6	induced	_	VBN	_	_	5	APPO	_	_
7	by	_	IN	_	_	6	VMOD	_	_
8	high	_	JJ	_	_	10	NMOD	_	_
9	antigen	_	NN	_	_	10	NMOD	_	_
10	dose	_	NN	_	_	7	PMOD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	IL-12	_	NN	_	_	11	CONJ	_	_
13	was	_	VBD	_	_	0	ROOT	_	_
14	independent	_	JJ	_	_	13	VMOD	_	_
15	of	_	IN	_	_	14	AMOD	_	_
16	IFN-gamma	_	NN	_	_	15	PMOD	_	_
17	,	_	,	_	_	13	P	_	_
18	in	_	IN	_	_	13	VMOD	_	_
19	keeping	_	VBG	_	_	18	PMOD	_	_
20	with	_	IN	_	_	19	VMOD	_	_
21	previous	_	JJ	_	_	22	NMOD	_	_
22	findings	_	NNS	_	_	20	PMOD	_	_
23	(	_	(	_	_	24	P	_	_
24	Jankovic	_	NNP	_	_	22	PRN	_	_
25	et	_	FW	_	_	24	NMOD	_	_
26	al.	_	FW	_	_	24	NMOD	_	_
27	,	_	,	_	_	24	P	_	_
28	2002	_	CD	_	_	24	APPO	_	_
29	)	_	)	_	_	24	P	_	_
30	.	_	.	_	_	13	P	_	_
		
1	However	_	RB	_	_	20	VMOD	_	_
2	,	_	,	_	_	20	P	_	_
3	a	_	DT	_	_	4	NMOD	_	_
4	role	_	NN	_	_	20	VMOD	_	_
5	for	_	IN	_	_	4	NMOD	_	_
6	IFN-gamma	_	NN	_	_	5	PMOD	_	_
7	in	_	IN	_	_	4	NMOD	_	_
8	mediating	_	VBG	_	_	7	PMOD	_	_
9	IL-10	_	NN	_	_	10	NMOD	_	_
10	reactivation	_	NN	_	_	8	VMOD	_	_
11	by	_	IN	_	_	10	NMOD	_	_
12	Th1	_	NN	_	_	13	NMOD	_	_
13	cells	_	NNS	_	_	11	PMOD	_	_
14	during	_	IN	_	_	8	VMOD	_	_
15	secondary	_	JJ	_	_	16	NMOD	_	_
16	infection	_	NN	_	_	14	PMOD	_	_
17	with	_	IN	_	_	16	NMOD	_	_
18	T.	_	FW	_	_	19	NMOD	_	_
19	gondii	_	FW	_	_	17	PMOD	_	_
20	has	_	VBZ	_	_	0	ROOT	_	_
21	been	_	VBN	_	_	20	VC	_	_
22	suggested	_	VBN	_	_	21	VC	_	_
23	(	_	(	_	_	24	P	_	_
24	Shaw	_	NNP	_	_	22	PRN	_	_
25	et	_	FW	_	_	24	NMOD	_	_
26	al.	_	FW	_	_	24	NMOD	_	_
27	,	_	,	_	_	24	P	_	_
28	2006	_	NN	_	_	24	APPO	_	_
29	)	_	)	_	_	24	P	_	_
30	.	_	.	_	_	20	P	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	have	_	VBP	_	_	0	ROOT	_	_
3	found	_	VBN	_	_	2	VC	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	CD4+	_	JJ	_	_	7	NMOD	_	_
6	T	_	NN	_	_	7	NMOD	_	_
7	cells	_	NNS	_	_	15	VMOD	_	_
8	exposed	_	VBN	_	_	7	APPO	_	_
9	to	_	TO	_	_	8	VMOD	_	_
10	a	_	DT	_	_	12	NMOD	_	_
11	high	_	JJ	_	_	12	NMOD	_	_
12	dose	_	NN	_	_	9	PMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	antigen	_	NN	_	_	13	PMOD	_	_
15	do	_	VBP	_	_	4	SUB	_	_
16	not	_	RB	_	_	15	VMOD	_	_
17	express	_	VB	_	_	15	VC	_	_
18	IL-10	_	NN	_	_	17	VMOD	_	_
19	upon	_	IN	_	_	17	VMOD	_	_
20	restimulation	_	NN	_	_	19	PMOD	_	_
21	,	_	,	_	_	15	P	_	_
22	but	_	CC	_	_	15	COORD	_	_
23	can	_	MD	_	_	22	CONJ	_	_
24	be	_	VB	_	_	23	VC	_	_
25	induced	_	VBN	_	_	24	VC	_	_
26	to	_	TO	_	_	25	VMOD	_	_
27	produce	_	VB	_	_	26	IM	_	_
28	IL-10	_	NN	_	_	27	VMOD	_	_
29	upon	_	IN	_	_	27	VMOD	_	_
30	re-exposure	_	NN	_	_	29	PMOD	_	_
31	to	_	TO	_	_	30	NMOD	_	_
32	a	_	DT	_	_	34	NMOD	_	_
33	high	_	JJ	_	_	34	NMOD	_	_
34	dose	_	NN	_	_	31	PMOD	_	_
35	of	_	IN	_	_	34	NMOD	_	_
36	antigen	_	NN	_	_	35	PMOD	_	_
37	in	_	IN	_	_	27	VMOD	_	_
38	the	_	DT	_	_	40	NMOD	_	_
39	recall	_	NN	_	_	40	NMOD	_	_
40	phase	_	NN	_	_	37	PMOD	_	_
41	in	_	IN	_	_	40	NMOD	_	_
42	the	_	DT	_	_	43	NMOD	_	_
43	absence	_	NN	_	_	41	PMOD	_	_
44	of	_	IN	_	_	43	NMOD	_	_
45	added	_	VBN	_	_	46	NMOD	_	_
46	IL-12	_	NN	_	_	44	PMOD	_	_
47	.	_	.	_	_	2	P	_	_
		
1	However	_	RB	_	_	4	VMOD	_	_
2	,	_	,	_	_	4	P	_	_
3	this	_	DT	_	_	4	VMOD	_	_
4	is	_	VBZ	_	_	0	ROOT	_	_
5	dependent	_	JJ	_	_	4	VMOD	_	_
6	on	_	IN	_	_	5	AMOD	_	_
7	the	_	DT	_	_	8	NMOD	_	_
8	induction	_	NN	_	_	6	PMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	IL-12	_	NN	_	_	9	PMOD	_	_
11	by	_	IN	_	_	8	NMOD	_	_
12	antigen-presenting	_	JJ	_	_	13	NMOD	_	_
13	DCs	_	NNS	_	_	11	PMOD	_	_
14	.	_	.	_	_	4	P	_	_
		
1	The	_	DT	_	_	2	NMOD	_	_
2	combination	_	NN	_	_	10	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	both	_	CC	_	_	7	DEP	_	_
5	high	_	JJ	_	_	7	NMOD	_	_
6	antigen	_	NN	_	_	7	NMOD	_	_
7	dose	_	NN	_	_	3	PMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	IL-12	_	NN	_	_	8	CONJ	_	_
10	resulted	_	VBD	_	_	0	ROOT	_	_
11	in	_	IN	_	_	10	VMOD	_	_
12	the	_	DT	_	_	14	NMOD	_	_
13	highest	_	JJS	_	_	14	NMOD	_	_
14	levels	_	NNS	_	_	11	PMOD	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	IL-10	_	NN	_	_	17	NMOD	_	_
17	production	_	NN	_	_	15	PMOD	_	_
18	and	_	CC	_	_	10	COORD	_	_
19	correlated	_	VBD	_	_	18	CONJ	_	_
20	with	_	IN	_	_	19	VMOD	_	_
21	the	_	DT	_	_	23	NMOD	_	_
22	high	_	JJ	_	_	23	NMOD	_	_
23	levels	_	NNS	_	_	20	PMOD	_	_
24	of	_	IN	_	_	23	NMOD	_	_
25	ERK1	_	NN	_	_	24	PMOD	_	_
26	and	_	CC	_	_	25	COORD	_	_
27	ERK2	_	NN	_	_	26	CONJ	_	_
28	activation	_	NN	_	_	27	COORD	_	_
29	.	_	.	_	_	10	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	increased	_	VBN	_	_	3	NMOD	_	_
3	expression	_	NN	_	_	11	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	IFN-gamma	_	NN	_	_	4	PMOD	_	_
6	observed	_	VBN	_	_	3	APPO	_	_
7	during	_	IN	_	_	6	VMOD	_	_
8	the	_	DT	_	_	10	NMOD	_	_
9	secondary	_	JJ	_	_	10	NMOD	_	_
10	phase	_	NN	_	_	7	PMOD	_	_
11	will	_	MD	_	_	0	ROOT	_	_
12	induce	_	VB	_	_	11	VC	_	_
13	increased	_	VBN	_	_	15	NMOD	_	_
14	IL-12	_	NN	_	_	15	NMOD	_	_
15	production	_	NN	_	_	12	VMOD	_	_
16	by	_	IN	_	_	15	NMOD	_	_
17	DCs	_	NNS	_	_	16	PMOD	_	_
18	and	_	CC	_	_	11	COORD	_	_
19	suggests	_	VBZ	_	_	18	CONJ	_	_
20	that	_	IN	_	_	19	VMOD	_	_
21	repeated	_	JJ	_	_	24	NMOD	_	_
22	high-level	_	JJ	_	_	24	NMOD	_	_
23	TCR	_	NN	_	_	24	NMOD	_	_
24	activation	_	NN	_	_	25	VMOD	_	_
25	feeds	_	VBZ	_	_	20	SUB	_	_
26	back	_	RB	_	_	25	VMOD	_	_
27	to	_	TO	_	_	25	VMOD	_	_
28	upregulate	_	VB	_	_	27	IM	_	_
29	IL-12	_	NN	_	_	30	NMOD	_	_
30	production	_	NN	_	_	28	VMOD	_	_
31	by	_	IN	_	_	30	NMOD	_	_
32	DC	_	NNS	_	_	31	PMOD	_	_
33	.	_	.	_	_	11	P	_	_
		
1	It	_	PRP	_	_	2	VMOD	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	thus	_	RB	_	_	2	VMOD	_	_
4	likely	_	JJ	_	_	2	VMOD	_	_
5	that	_	IN	_	_	4	AMOD	_	_
6	in	_	IN	_	_	28	VMOD	_	_
7	T.	_	FW	_	_	8	AMOD	_	_
8	gondii	_	FW	_	_	9	NMOD	_	_
9	infection	_	NN	_	_	6	PMOD	_	_
10	in	_	FW	_	_	9	NMOD	_	_
11	vivo	_	FW	_	_	10	AMOD	_	_
12	(	_	(	_	_	13	P	_	_
13	Shaw	_	NNP	_	_	10	PRN	_	_
14	et	_	FW	_	_	13	NMOD	_	_
15	al.	_	FW	_	_	13	NMOD	_	_
16	,	_	,	_	_	13	P	_	_
17	2006	_	NN	_	_	13	APPO	_	_
18	)	_	)	_	_	13	P	_	_
19	,	_	,	_	_	28	P	_	_
20	the	_	DT	_	_	21	NMOD	_	_
21	requirement	_	NN	_	_	28	VMOD	_	_
22	for	_	IN	_	_	21	NMOD	_	_
23	IFN-gamma	_	NN	_	_	22	PMOD	_	_
24	to	_	TO	_	_	21	NMOD	_	_
25	induce	_	VB	_	_	24	IM	_	_
26	IL-10	_	NN	_	_	25	VMOD	_	_
27	,	_	,	_	_	21	P	_	_
28	was	_	VBD	_	_	5	SUB	_	_
29	for	_	IN	_	_	28	VMOD	_	_
30	feedback	_	NN	_	_	31	NMOD	_	_
31	upregulation	_	NN	_	_	29	PMOD	_	_
32	of	_	IN	_	_	31	NMOD	_	_
33	IL-12	_	NN	_	_	32	PMOD	_	_
34	by	_	IN	_	_	31	NMOD	_	_
35	DCs	_	NNS	_	_	34	PMOD	_	_
36	,	_	,	_	_	35	P	_	_
37	which	_	WDT	_	_	40	VMOD	_	_
38	in	_	IN	_	_	40	VMOD	_	_
39	turn	_	NN	_	_	38	PMOD	_	_
40	induced	_	VBD	_	_	35	NMOD	_	_
41	IL-10	_	NN	_	_	40	VMOD	_	_
42	in	_	IN	_	_	40	VMOD	_	_
43	the	_	DT	_	_	45	NMOD	_	_
44	Th1	_	NN	_	_	45	NMOD	_	_
45	cells	_	NNS	_	_	42	PMOD	_	_
46	.	_	.	_	_	2	P	_	_
		
1	Although	_	IN	_	_	0	ROOT	_	_
2	IL-10	_	NN	_	_	3	VMOD	_	_
3	may	_	MD	_	_	1	SUB	_	_
4	be	_	VB	_	_	3	VC	_	_
5	differentially	_	RB	_	_	4	VMOD	_	_
6	regulated	_	VBN	_	_	4	VC	_	_
7	in	_	IN	_	_	6	VMOD	_	_
8	Th1	_	NN	_	_	11	NMOD	_	_
9	and	_	CC	_	_	8	COORD	_	_
10	Th2	_	NN	_	_	9	CONJ	_	_
11	cells	_	NNS	_	_	7	PMOD	_	_
12	as	_	IN	_	_	6	VMOD	_	_
13	has	_	VBZ	_	_	12	SUB	_	_
14	been	_	VBN	_	_	13	VC	_	_
15	reported	_	VBN	_	_	14	VC	_	_
16	(	_	(	_	_	17	P	_	_
17	Chang	_	NNP	_	_	15	PRN	_	_
18	et	_	FW	_	_	17	NMOD	_	_
19	al.	_	FW	_	_	17	NMOD	_	_
20	,	_	,	_	_	17	P	_	_
21	2007	_	CD	_	_	17	NMOD	_	_
22	;	_	:	_	_	17	P	_	_
23	Wang	_	NNP	_	_	17	APPO	_	_
24	et	_	FW	_	_	23	NMOD	_	_
25	al.	_	FW	_	_	23	NMOD	_	_
26	,	_	,	_	_	23	P	_	_
27	2005	_	CD	_	_	23	NMOD	_	_
28	)	_	)	_	_	17	P	_	_
29	,	_	,	_	_	1	P	_	_
30	some	_	DT	_	_	31	NMOD	_	_
31	studies	_	NNS	_	_	32	VMOD	_	_
32	suggest	_	VBP	_	_	1	COORD	_	_
33	the	_	DT	_	_	34	NMOD	_	_
34	existence	_	NN	_	_	32	VMOD	_	_
35	of	_	IN	_	_	34	NMOD	_	_
36	common	_	JJ	_	_	37	NMOD	_	_
37	pathways	_	NNS	_	_	35	PMOD	_	_
38	,	_	,	_	_	32	P	_	_
39	but	_	CC	_	_	32	COORD	_	_
40	the	_	DT	_	_	42	NMOD	_	_
41	molecular	_	JJ	_	_	42	NMOD	_	_
42	basis	_	NN	_	_	45	VMOD	_	_
43	for	_	IN	_	_	42	NMOD	_	_
44	these	_	DT	_	_	43	PMOD	_	_
45	is	_	VBZ	_	_	39	CONJ	_	_
46	as	_	RB	_	_	45	VMOD	_	_
47	yet	_	RB	_	_	46	AMOD	_	_
48	unclear	_	JJ	_	_	46	AMOD	_	_
49	.	_	.	_	_	1	P	_	_
		
1	Costimulatory	_	JJ	_	_	3	NMOD	_	_
2	OX-40	_	NN	_	_	3	NMOD	_	_
3	signals	_	NNS	_	_	4	VMOD	_	_
4	have	_	VBP	_	_	0	ROOT	_	_
5	been	_	VBN	_	_	4	VC	_	_
6	shown	_	VBN	_	_	5	VC	_	_
7	to	_	TO	_	_	6	VMOD	_	_
8	negatively	_	RB	_	_	9	VMOD	_	_
9	regulate	_	VB	_	_	7	IM	_	_
10	IL-10	_	NN	_	_	11	NMOD	_	_
11	production	_	NN	_	_	9	VMOD	_	_
12	(	_	(	_	_	13	P	_	_
13	Ito	_	NN	_	_	11	PRN	_	_
14	et	_	FW	_	_	13	NMOD	_	_
15	al.	_	FW	_	_	13	NMOD	_	_
16	,	_	,	_	_	13	P	_	_
17	2005	_	CD	_	_	13	NMOD	_	_
18	)	_	)	_	_	13	P	_	_
19	both	_	CC	_	_	20	DEP	_	_
20	in	_	IN	_	_	11	NMOD	_	_
21	Th1	_	NN	_	_	24	NMOD	_	_
22	and	_	CC	_	_	21	COORD	_	_
23	Th2	_	NN	_	_	22	CONJ	_	_
24	cells	_	NNS	_	_	20	PMOD	_	_
25	,	_	,	_	_	4	P	_	_
26	whereas	_	IN	_	_	4	COORD	_	_
27	ICOS	_	NN	_	_	28	NMOD	_	_
28	signaling	_	NN	_	_	29	VMOD	_	_
29	has	_	VBZ	_	_	26	COORD	_	_
30	been	_	VBN	_	_	29	VC	_	_
31	suggested	_	VBN	_	_	30	VC	_	_
32	to	_	TO	_	_	31	VMOD	_	_
33	induce	_	VB	_	_	32	IM	_	_
34	IL-10	_	NN	_	_	33	VMOD	_	_
35	(	_	(	_	_	36	P	_	_
36	Ito	_	NN	_	_	33	PRN	_	_
37	et	_	FW	_	_	36	NMOD	_	_
38	al.	_	FW	_	_	36	NMOD	_	_
39	,	_	,	_	_	36	P	_	_
40	2007	_	CD	_	_	36	NMOD	_	_
41	;	_	:	_	_	36	P	_	_
42	Witsch	_	NNP	_	_	36	COORD	_	_
43	et	_	FW	_	_	42	NMOD	_	_
44	al.	_	FW	_	_	42	NMOD	_	_
45	,	_	,	_	_	42	P	_	_
46	2002	_	CD	_	_	42	APPO	_	_
47	)	_	)	_	_	36	P	_	_
48	in	_	IN	_	_	33	VMOD	_	_
49	both	_	CC	_	_	53	DEP	_	_
50	Th1	_	NN	_	_	53	NMOD	_	_
51	and	_	CC	_	_	50	COORD	_	_
52	Th2	_	NN	_	_	51	CONJ	_	_
53	cells	_	NNS	_	_	48	PMOD	_	_
54	.	_	.	_	_	4	P	_	_
		
1	However	_	RB	_	_	10	VMOD	_	_
2	,	_	,	_	_	10	P	_	_
3	in	_	IN	_	_	10	VMOD	_	_
4	some	_	DT	_	_	5	NMOD	_	_
5	cases	_	NNS	_	_	3	PMOD	_	_
6	,	_	,	_	_	10	P	_	_
7	ICOS	_	NN	_	_	8	NMOD	_	_
8	signaling	_	NN	_	_	10	VMOD	_	_
9	also	_	RB	_	_	10	VMOD	_	_
10	regulates	_	VBZ	_	_	0	ROOT	_	_
11	IL-4	_	NN	_	_	12	NMOD	_	_
12	production	_	NN	_	_	10	VMOD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	Th2	_	NN	_	_	15	NMOD	_	_
15	responses	_	NNS	_	_	13	CONJ	_	_
16	(	_	(	_	_	17	P	_	_
17	Greenwald	_	NNP	_	_	10	PRN	_	_
18	et	_	FW	_	_	17	NMOD	_	_
19	al.	_	FW	_	_	17	NMOD	_	_
20	,	_	,	_	_	17	P	_	_
21	2005	_	CD	_	_	17	APPO	_	_
22	)	_	)	_	_	17	P	_	_
23	.	_	.	_	_	10	P	_	_
		
1	We	_	PRP	_	_	3	VMOD	_	_
2	now	_	RB	_	_	3	VMOD	_	_
3	provide	_	VBP	_	_	0	ROOT	_	_
4	a	_	DT	_	_	6	NMOD	_	_
5	common	_	JJ	_	_	6	NMOD	_	_
6	mechanism	_	NN	_	_	3	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	ERK1	_	NN	_	_	7	PMOD	_	_
9	and	_	CC	_	_	8	COORD	_	_
10	ERK2	_	NN	_	_	9	CONJ	_	_
11	activation	_	NN	_	_	10	COORD	_	_
12	for	_	IN	_	_	6	NMOD	_	_
13	the	_	DT	_	_	14	NMOD	_	_
14	regulation	_	NN	_	_	12	PMOD	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	IL-10	_	NN	_	_	17	NMOD	_	_
17	production	_	NN	_	_	15	PMOD	_	_
18	in	_	IN	_	_	14	NMOD	_	_
19	Th1	_	NN	_	_	18	PMOD	_	_
20	,	_	,	_	_	19	P	_	_
21	Th2	_	NN	_	_	19	COORD	_	_
22	,	_	,	_	_	21	P	_	_
23	and	_	CC	_	_	21	COORD	_	_
24	Th17	_	NN	_	_	25	NMOD	_	_
25	cells	_	NNS	_	_	23	CONJ	_	_
26	,	_	,	_	_	3	P	_	_
27	although	_	IN	_	_	3	VMOD	_	_
28	each	_	DT	_	_	29	NMOD	_	_
29	subset	_	NN	_	_	30	VMOD	_	_
30	differentiates	_	VBZ	_	_	27	SUB	_	_
31	along	_	IN	_	_	30	VMOD	_	_
32	a	_	DT	_	_	37	NMOD	_	_
33	distinct	_	JJ	_	_	37	NMOD	_	_
34	and	_	CC	_	_	33	COORD	_	_
35	subset-specific	_	JJ	_	_	34	CONJ	_	_
36	transcriptional	_	JJ	_	_	37	NMOD	_	_
37	pathway	_	NN	_	_	31	PMOD	_	_
38	.	_	.	_	_	3	P	_	_
		
1	This	_	DT	_	_	2	VMOD	_	_
2	reinforces	_	VBZ	_	_	0	ROOT	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	fact	_	NN	_	_	2	VMOD	_	_
5	that	_	IN	_	_	4	NMOD	_	_
6	IL-10	_	NN	_	_	7	VMOD	_	_
7	is	_	VBZ	_	_	5	SUB	_	_
8	not	_	RB	_	_	7	VMOD	_	_
9	a	_	DT	_	_	12	NMOD	_	_
10	Th	_	NN	_	_	12	NMOD	_	_
11	cell-subset-specific	_	JJ	_	_	12	NMOD	_	_
12	cytokine	_	NN	_	_	7	VMOD	_	_
13	,	_	,	_	_	7	P	_	_
14	but	_	CC	_	_	7	COORD	_	_
15	instead	_	RB	_	_	7	VMOD	_	_
16	is	_	VBZ	_	_	14	CONJ	_	_
17	produced	_	VBN	_	_	16	VC	_	_
18	in	_	IN	_	_	17	VMOD	_	_
19	a	_	DT	_	_	22	NMOD	_	_
20	tightly	_	RB	_	_	21	AMOD	_	_
21	regulated	_	VBN	_	_	22	NMOD	_	_
22	fashion	_	NN	_	_	18	PMOD	_	_
23	during	_	IN	_	_	17	VMOD	_	_
24	each	_	DT	_	_	26	NMOD	_	_
25	differentiation	_	NN	_	_	26	NMOD	_	_
26	pathway	_	NN	_	_	23	PMOD	_	_
27	.	_	.	_	_	2	P	_	_
		
1	Of	_	IN	_	_	17	VMOD	_	_
2	note	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	17	P	_	_
4	a	_	DT	_	_	5	NMOD	_	_
5	role	_	NN	_	_	17	VMOD	_	_
6	for	_	IN	_	_	5	NMOD	_	_
7	ERK1	_	NN	_	_	10	NMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	ERK2	_	NN	_	_	8	CONJ	_	_
10	activation	_	NN	_	_	6	PMOD	_	_
11	in	_	IN	_	_	5	NMOD	_	_
12	the	_	DT	_	_	13	NMOD	_	_
13	induction	_	NN	_	_	11	PMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	IL-10	_	NN	_	_	16	NMOD	_	_
16	production	_	NN	_	_	14	PMOD	_	_
17	has	_	VBZ	_	_	0	ROOT	_	_
18	already	_	RB	_	_	17	VMOD	_	_
19	been	_	VBN	_	_	17	VC	_	_
20	described	_	VBN	_	_	19	VC	_	_
21	for	_	IN	_	_	20	VMOD	_	_
22	macrophages	_	NNS	_	_	21	PMOD	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	DC	_	NN	_	_	23	CONJ	_	_
25	(	_	(	_	_	26	P	_	_
26	Agrawal	_	NNP	_	_	20	PRN	_	_
27	et	_	FW	_	_	26	NMOD	_	_
28	al.	_	FW	_	_	26	NMOD	_	_
29	,	_	,	_	_	26	P	_	_
30	2006	_	NN	_	_	26	NMOD	_	_
31	;	_	:	_	_	26	P	_	_
32	Hacker	_	NNP	_	_	26	APPO	_	_
33	et	_	FW	_	_	32	NMOD	_	_
34	al.	_	FW	_	_	32	NMOD	_	_
35	,	_	,	_	_	32	P	_	_
36	1999	_	CD	_	_	32	NMOD	_	_
37	)	_	)	_	_	26	P	_	_
38	.	_	.	_	_	17	P	_	_
		
1	Differential	_	JJ	_	_	3	NMOD	_	_
2	transcriptional	_	JJ	_	_	3	NMOD	_	_
3	regulation	_	NN	_	_	11	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	IL-10	_	NN	_	_	4	PMOD	_	_
6	in	_	IN	_	_	3	NMOD	_	_
7	Th1	_	NN	_	_	10	NMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	Th2	_	NN	_	_	8	CONJ	_	_
10	cells	_	NNS	_	_	6	PMOD	_	_
11	has	_	VBZ	_	_	0	ROOT	_	_
12	been	_	VBN	_	_	11	VC	_	_
13	suggested	_	VBN	_	_	12	VC	_	_
14	(	_	(	_	_	15	P	_	_
15	Chang	_	NNP	_	_	13	PRN	_	_
16	et	_	FW	_	_	15	NMOD	_	_
17	al.	_	FW	_	_	15	NMOD	_	_
18	,	_	,	_	_	15	P	_	_
19	2007	_	CD	_	_	15	NMOD	_	_
20	;	_	:	_	_	15	P	_	_
21	Wang	_	NNP	_	_	15	APPO	_	_
22	et	_	FW	_	_	21	NMOD	_	_
23	al.	_	FW	_	_	21	NMOD	_	_
24	,	_	,	_	_	21	P	_	_
25	2005	_	CD	_	_	21	NMOD	_	_
26	)	_	)	_	_	15	P	_	_
27	,	_	,	_	_	11	P	_	_
28	and	_	CC	_	_	11	COORD	_	_
29	extensive	_	JJ	_	_	31	NMOD	_	_
30	histone	_	NN	_	_	31	NMOD	_	_
31	acetylation	_	NN	_	_	36	VMOD	_	_
32	of	_	IN	_	_	31	NMOD	_	_
33	the	_	DT	_	_	35	NMOD	_	_
34	IL-10	_	NN	_	_	35	NMOD	_	_
35	gene	_	NN	_	_	32	PMOD	_	_
36	is	_	VBZ	_	_	28	CONJ	_	_
37	detectable	_	JJ	_	_	36	VMOD	_	_
38	in	_	IN	_	_	37	AMOD	_	_
39	fully	_	RB	_	_	40	AMOD	_	_
40	polarized	_	VBN	_	_	42	NMOD	_	_
41	Th2	_	NN	_	_	42	NMOD	_	_
42	cells	_	NNS	_	_	38	PMOD	_	_
43	,	_	,	_	_	42	P	_	_
44	but	_	CC	_	_	42	COORD	_	_
45	not	_	RB	_	_	44	COORD	_	_
46	Th1	_	NN	_	_	47	NMOD	_	_
47	cells	_	NNS	_	_	44	CONJ	_	_
48	(	_	(	_	_	49	P	_	_
49	Chang	_	NNP	_	_	36	PRN	_	_
50	et	_	FW	_	_	49	NMOD	_	_
51	al.	_	FW	_	_	49	NMOD	_	_
52	,	_	,	_	_	49	P	_	_
53	2007	_	CD	_	_	49	NMOD	_	_
54	)	_	)	_	_	49	P	_	_
55	.	_	.	_	_	11	P	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	provide	_	VBP	_	_	0	ROOT	_	_
3	evidence	_	NN	_	_	2	VMOD	_	_
4	that	_	IN	_	_	3	NMOD	_	_
5	IL-10	_	NN	_	_	6	VMOD	_	_
6	is	_	VBZ	_	_	4	SUB	_	_
7	produced	_	VBN	_	_	6	VC	_	_
8	in	_	IN	_	_	7	VMOD	_	_
9	canonical	_	JJ	_	_	11	NMOD	_	_
10	Th1	_	NN	_	_	11	NMOD	_	_
11	cells	_	NNS	_	_	8	PMOD	_	_
12	and	_	CC	_	_	4	COORD	_	_
13	that	_	IN	_	_	12	CONJ	_	_
14	its	_	PRP$	_	_	15	NMOD	_	_
15	expression	_	NN	_	_	16	VMOD	_	_
16	correlates	_	VBZ	_	_	13	SUB	_	_
17	with	_	IN	_	_	16	VMOD	_	_
18	the	_	DT	_	_	19	NMOD	_	_
19	expression	_	NN	_	_	17	PMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	T-bet	_	NN	_	_	20	PMOD	_	_
22	and	_	CC	_	_	19	COORD	_	_
23	the	_	DT	_	_	26	NMOD	_	_
24	highest	_	JJS	_	_	26	NMOD	_	_
25	IFN-gamma	_	NN	_	_	26	NMOD	_	_
26	production	_	NN	_	_	22	CONJ	_	_
27	,	_	,	_	_	16	P	_	_
28	in	_	IN	_	_	16	VMOD	_	_
29	keeping	_	VBG	_	_	28	PMOD	_	_
30	with	_	IN	_	_	29	VMOD	_	_
31	our	_	PRP$	_	_	32	NMOD	_	_
32	observations	_	NNS	_	_	30	PMOD	_	_
33	that	_	IN	_	_	32	NMOD	_	_
34	high-dose	_	JJ	_	_	36	NMOD	_	_
35	antigen	_	NN	_	_	36	NMOD	_	_
36	stimulation	_	NN	_	_	40	VMOD	_	_
37	and	_	CC	_	_	36	COORD	_	_
38	IL-12	_	NN	_	_	39	NMOD	_	_
39	signaling	_	NN	_	_	37	CONJ	_	_
40	are	_	VBP	_	_	33	SUB	_	_
41	required	_	VBN	_	_	40	VC	_	_
42	for	_	IN	_	_	41	VMOD	_	_
43	IL-10	_	NN	_	_	46	NMOD	_	_
44	and	_	CC	_	_	43	COORD	_	_
45	IFN-gamma	_	NN	_	_	44	CONJ	_	_
46	expression	_	NN	_	_	42	PMOD	_	_
47	.	_	.	_	_	2	P	_	_
		
1	It	_	PRP	_	_	2	VMOD	_	_
2	has	_	VBZ	_	_	0	ROOT	_	_
3	also	_	RB	_	_	2	VMOD	_	_
4	been	_	VBN	_	_	2	VC	_	_
5	shown	_	VBN	_	_	4	VC	_	_
6	that	_	IN	_	_	5	VMOD	_	_
7	maintenance	_	NN	_	_	11	VMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	IL-10	_	NN	_	_	10	NMOD	_	_
10	expression	_	NN	_	_	8	PMOD	_	_
11	is	_	VBZ	_	_	6	SUB	_	_
12	conditional	_	JJ	_	_	11	VMOD	_	_
13	on	_	IN	_	_	12	AMOD	_	_
14	IL-12	_	NN	_	_	13	PMOD	_	_
15	or	_	CC	_	_	14	COORD	_	_
16	IL-4	_	NN	_	_	15	CONJ	_	_
17	unless	_	IN	_	_	11	VMOD	_	_
18	the	_	DT	_	_	20	NMOD	_	_
19	IL-10	_	NN	_	_	20	NMOD	_	_
20	gene	_	NN	_	_	21	VMOD	_	_
21	is	_	VBZ	_	_	17	SUB	_	_
22	imprinted	_	VBN	_	_	21	VC	_	_
23	by	_	IN	_	_	22	VMOD	_	_
24	GATA-3	_	NN	_	_	23	PMOD	_	_
25	(	_	(	_	_	26	P	_	_
26	Chang	_	NNP	_	_	24	PRN	_	_
27	et	_	FW	_	_	26	NMOD	_	_
28	al.	_	FW	_	_	26	NMOD	_	_
29	,	_	,	_	_	26	P	_	_
30	2007	_	CD	_	_	26	NMOD	_	_
31	)	_	)	_	_	26	P	_	_
32	,	_	,	_	_	24	P	_	_
33	which	_	WDT	_	_	34	VMOD	_	_
34	can	_	MD	_	_	24	NMOD	_	_
35	remodel	_	VB	_	_	34	VC	_	_
36	the	_	DT	_	_	38	NMOD	_	_
37	IL-10	_	NN	_	_	38	NMOD	_	_
38	locus	_	NN	_	_	35	VMOD	_	_
39	,	_	,	_	_	35	P	_	_
40	thus	_	RB	_	_	41	VMOD	_	_
41	explaining	_	VBG	_	_	35	VMOD	_	_
42	the	_	DT	_	_	44	NMOD	_	_
43	highest	_	JJS	_	_	44	NMOD	_	_
44	amounts	_	NNS	_	_	41	VMOD	_	_
45	of	_	IN	_	_	44	NMOD	_	_
46	IL-10	_	NN	_	_	45	PMOD	_	_
47	produced	_	VBN	_	_	46	APPO	_	_
48	by	_	IN	_	_	47	VMOD	_	_
49	Th2	_	NN	_	_	50	NMOD	_	_
50	cells	_	NNS	_	_	48	PMOD	_	_
51	(	_	(	_	_	52	P	_	_
52	Chang	_	NNP	_	_	50	PRN	_	_
53	et	_	FW	_	_	52	NMOD	_	_
54	al.	_	FW	_	_	52	NMOD	_	_
55	,	_	,	_	_	52	P	_	_
56	2007	_	CD	_	_	52	NMOD	_	_
57	;	_	:	_	_	52	P	_	_
58	Shoemaker	_	NNP	_	_	52	APPO	_	_
59	et	_	FW	_	_	58	NMOD	_	_
60	al.	_	FW	_	_	58	NMOD	_	_
61	,	_	,	_	_	58	P	_	_
62	2006	_	NN	_	_	58	NMOD	_	_
63	)	_	)	_	_	52	P	_	_
64	.	_	.	_	_	2	P	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	show	_	VBP	_	_	0	ROOT	_	_
3	here	_	RB	_	_	2	VMOD	_	_
4	that	_	IN	_	_	2	VMOD	_	_
5	high	_	JJ	_	_	7	NMOD	_	_
6	antigen	_	NN	_	_	7	NMOD	_	_
7	dose	_	NN	_	_	11	VMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	IL-12	_	NN	_	_	8	CONJ	_	_
10	drastically	_	RB	_	_	11	VMOD	_	_
11	downregulate	_	VBP	_	_	4	SUB	_	_
12	Gata-3	_	NN	_	_	13	NMOD	_	_
13	expression	_	NN	_	_	11	VMOD	_	_
14	,	_	,	_	_	11	P	_	_
15	suggesting	_	VBG	_	_	11	VMOD	_	_
16	that	_	IN	_	_	15	VMOD	_	_
17	additional	_	JJ	_	_	18	NMOD	_	_
18	factors	_	NNS	_	_	19	VMOD	_	_
19	are	_	VBP	_	_	16	SUB	_	_
20	in	_	IN	_	_	19	VMOD	_	_
21	place	_	NN	_	_	20	PMOD	_	_
22	to	_	TO	_	_	19	VC	_	_
23	induce	_	VB	_	_	22	IM	_	_
24	IL-10	_	NN	_	_	25	NMOD	_	_
25	expression	_	NN	_	_	23	VMOD	_	_
26	in	_	IN	_	_	23	VMOD	_	_
27	Th1	_	NN	_	_	28	NMOD	_	_
28	cells	_	NNS	_	_	26	PMOD	_	_
29	,	_	,	_	_	23	P	_	_
30	albeit	_	IN	_	_	23	VMOD	_	_
31	transiently	_	RB	_	_	30	VMOD	_	_
32	.	_	.	_	_	2	P	_	_
		
1	Expression	_	NN	_	_	4	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	c-maf	_	NN	_	_	2	PMOD	_	_
4	was	_	VBD	_	_	0	ROOT	_	_
5	greatly	_	RB	_	_	4	VMOD	_	_
6	diminished	_	VBN	_	_	4	VC	_	_
7	by	_	IN	_	_	6	VMOD	_	_
8	high	_	JJ	_	_	10	NMOD	_	_
9	antigen	_	NN	_	_	10	NMOD	_	_
10	doses	_	NNS	_	_	7	PMOD	_	_
11	in	_	IN	_	_	6	VMOD	_	_
12	T	_	NN	_	_	13	NMOD	_	_
13	cells	_	NNS	_	_	11	PMOD	_	_
14	and	_	CC	_	_	4	COORD	_	_
15	yet	_	RB	_	_	4	VMOD	_	_
16	was	_	VBD	_	_	14	CONJ	_	_
17	unexpectedly	_	RB	_	_	16	VMOD	_	_
18	maintained	_	VBN	_	_	16	VC	_	_
19	by	_	IN	_	_	18	VMOD	_	_
20	IL-12	_	NN	_	_	19	PMOD	_	_
21	and	_	CC	_	_	20	COORD	_	_
22	present	_	NN	_	_	21	CONJ	_	_
23	in	_	IN	_	_	18	VMOD	_	_
24	Th17	_	NN	_	_	25	NMOD	_	_
25	cells	_	NNS	_	_	23	PMOD	_	_
26	.	_	.	_	_	4	P	_	_
		
1	That	_	DT	_	_	3	NMOD	_	_
2	c-maf	_	NN	_	_	3	NMOD	_	_
3	expression	_	NN	_	_	4	VMOD	_	_
4	is	_	VBZ	_	_	0	ROOT	_	_
5	common	_	JJ	_	_	4	VMOD	_	_
6	to	_	TO	_	_	5	AMOD	_	_
7	IL-10-producing	_	JJ	_	_	8	NMOD	_	_
8	Th1	_	NN	_	_	6	PMOD	_	_
9	,	_	,	_	_	8	P	_	_
10	Th2	_	NN	_	_	8	COORD	_	_
11	,	_	,	_	_	10	P	_	_
12	and	_	CC	_	_	10	COORD	_	_
13	Th17	_	NN	_	_	14	NMOD	_	_
14	cells	_	NNS	_	_	12	CONJ	_	_
15	and	_	CC	_	_	4	COORD	_	_
16	,	_	,	_	_	15	P	_	_
17	like	_	IN	_	_	4	VMOD	_	_
18	IL-10	_	NN	_	_	17	PMOD	_	_
19	,	_	,	_	_	15	P	_	_
20	is	_	VBZ	_	_	15	CONJ	_	_
21	dependent	_	JJ	_	_	20	VMOD	_	_
22	on	_	IN	_	_	21	AMOD	_	_
23	ERK	_	NN	_	_	24	NMOD	_	_
24	activation	_	NN	_	_	22	PMOD	_	_
25	in	_	IN	_	_	24	NMOD	_	_
26	Th1	_	NN	_	_	29	NMOD	_	_
27	and	_	CC	_	_	26	COORD	_	_
28	Th17	_	NN	_	_	27	CONJ	_	_
29	cells	_	NNS	_	_	25	PMOD	_	_
30	for	_	IN	_	_	20	VMOD	_	_
31	its	_	PRP$	_	_	32	NMOD	_	_
32	expression	_	NN	_	_	33	VMOD	_	_
33	is	_	VBZ	_	_	30	SUB	_	_
34	of	_	IN	_	_	33	VMOD	_	_
35	interest	_	NN	_	_	34	PMOD	_	_
36	because	_	IN	_	_	33	VMOD	_	_
37	c-Maf	_	NN	_	_	38	VMOD	_	_
38	has	_	VBZ	_	_	36	SUB	_	_
39	been	_	VBN	_	_	38	VC	_	_
40	shown	_	VBN	_	_	39	VC	_	_
41	to	_	TO	_	_	40	VMOD	_	_
42	be	_	VB	_	_	41	IM	_	_
43	an	_	DT	_	_	46	NMOD	_	_
44	essential	_	JJ	_	_	46	NMOD	_	_
45	transcription	_	NN	_	_	46	NMOD	_	_
46	factor	_	NN	_	_	42	VMOD	_	_
47	for	_	IN	_	_	46	NMOD	_	_
48	IL-10	_	NN	_	_	49	NMOD	_	_
49	expression	_	NN	_	_	47	PMOD	_	_
50	in	_	IN	_	_	49	NMOD	_	_
51	macrophages	_	NNS	_	_	50	PMOD	_	_
52	(	_	(	_	_	53	P	_	_
53	Cao	_	NNP	_	_	51	PRN	_	_
54	et	_	FW	_	_	53	NMOD	_	_
55	al.	_	FW	_	_	53	NMOD	_	_
56	,	_	,	_	_	53	P	_	_
57	2005	_	CD	_	_	53	NMOD	_	_
58	)	_	)	_	_	53	P	_	_
59	.	_	.	_	_	4	P	_	_
		
1	In	_	IN	_	_	5	VMOD	_	_
2	summary	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	5	P	_	_
4	we	_	PRP	_	_	5	VMOD	_	_
5	show	_	VBP	_	_	0	ROOT	_	_
6	that	_	IN	_	_	5	VMOD	_	_
7	although	_	IN	_	_	27	VMOD	_	_
8	Th1	_	NN	_	_	17	NMOD	_	_
9	,	_	,	_	_	8	P	_	_
10	Th2	_	NN	_	_	8	COORD	_	_
11	,	_	,	_	_	10	P	_	_
12	and	_	CC	_	_	10	COORD	_	_
13	Th17	_	NN	_	_	12	CONJ	_	_
14	CD4+	_	JJ	_	_	17	NMOD	_	_
15	T	_	NN	_	_	17	NMOD	_	_
16	cell	_	NN	_	_	17	NMOD	_	_
17	subsets	_	NNS	_	_	18	VMOD	_	_
18	differentiate	_	VBP	_	_	7	SUB	_	_
19	along	_	IN	_	_	18	VMOD	_	_
20	distinct	_	JJ	_	_	24	NMOD	_	_
21	signaling	_	NN	_	_	24	COORD	_	_
22	and	_	CC	_	_	24	COORD	_	_
23	transcriptional	_	JJ	_	_	24	COORD	_	_
24	pathways	_	NNS	_	_	19	PMOD	_	_
25	,	_	,	_	_	27	P	_	_
26	they	_	PRP	_	_	27	VMOD	_	_
27	can	_	MD	_	_	6	SUB	_	_
28	all	_	RB	_	_	27	VMOD	_	_
29	be	_	VB	_	_	27	VC	_	_
30	induced	_	VBN	_	_	29	VC	_	_
31	to	_	TO	_	_	30	VMOD	_	_
32	make	_	VB	_	_	31	IM	_	_
33	IL-10	_	NN	_	_	32	VMOD	_	_
34	.	_	.	_	_	5	P	_	_
		
1	ERK1	_	NN	_	_	4	NMOD	_	_
2	and	_	CC	_	_	1	COORD	_	_
3	ERK2	_	NN	_	_	2	CONJ	_	_
4	activation	_	NN	_	_	5	VMOD	_	_
5	is	_	VBZ	_	_	0	ROOT	_	_
6	required	_	VBN	_	_	5	VC	_	_
7	for	_	IN	_	_	6	VMOD	_	_
8	IL-10	_	NN	_	_	9	NMOD	_	_
9	production	_	NN	_	_	7	PMOD	_	_
10	by	_	IN	_	_	9	NMOD	_	_
11	all	_	PDT	_	_	15	NMOD	_	_
12	these	_	DT	_	_	15	NMOD	_	_
13	Th	_	NN	_	_	15	NMOD	_	_
14	cell	_	NN	_	_	15	NMOD	_	_
15	subsets	_	NNS	_	_	10	PMOD	_	_
16	.	_	.	_	_	5	P	_	_
		
1	With	_	IN	_	_	14	VMOD	_	_
2	regard	_	NN	_	_	1	PMOD	_	_
3	to	_	TO	_	_	2	NMOD	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	expression	_	NN	_	_	3	PMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	IL-10	_	NN	_	_	6	PMOD	_	_
8	by	_	IN	_	_	5	NMOD	_	_
9	Th1	_	NN	_	_	10	NMOD	_	_
10	cells	_	NNS	_	_	8	PMOD	_	_
11	,	_	,	_	_	14	P	_	_
12	our	_	PRP$	_	_	13	NMOD	_	_
13	data	_	NNS	_	_	14	VMOD	_	_
14	provide	_	VBP	_	_	0	ROOT	_	_
15	a	_	DT	_	_	16	NMOD	_	_
16	mechanism	_	NN	_	_	14	VMOD	_	_
17	for	_	IN	_	_	16	NMOD	_	_
18	how	_	WRB	_	_	21	VMOD	_	_
19	IL-10	_	NN	_	_	20	NMOD	_	_
20	expression	_	NN	_	_	21	VMOD	_	_
21	is	_	VBZ	_	_	17	PMOD	_	_
22	induced	_	VBN	_	_	21	VC	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	then	_	RB	_	_	22	VMOD	_	_
25	amplified	_	VBN	_	_	23	CONJ	_	_
26	and	_	CC	_	_	25	COORD	_	_
27	regulated	_	VBN	_	_	26	CONJ	_	_
28	by	_	IN	_	_	27	VMOD	_	_
29	the	_	DT	_	_	30	NMOD	_	_
30	levels	_	NNS	_	_	28	PMOD	_	_
31	of	_	IN	_	_	30	NMOD	_	_
32	antigen	_	NN	_	_	31	PMOD	_	_
33	and	_	CC	_	_	32	COORD	_	_
34	IL-12	_	NN	_	_	33	CONJ	_	_
35	encountered	_	VBN	_	_	32	APPO	_	_
36	in	_	IN	_	_	35	VMOD	_	_
37	the	_	DT	_	_	38	NMOD	_	_
38	environment	_	NN	_	_	36	PMOD	_	_
39	.	_	.	_	_	14	P	_	_
		
1	This	_	DT	_	_	2	VMOD	_	_
2	provides	_	VBZ	_	_	0	ROOT	_	_
3	a	_	DT	_	_	4	NMOD	_	_
4	mechanism	_	NN	_	_	2	VMOD	_	_
5	whereby	_	WRB	_	_	9	VMOD	_	_
6	a	_	DT	_	_	8	NMOD	_	_
7	Th1	_	NN	_	_	8	NMOD	_	_
8	cell	_	NN	_	_	9	VMOD	_	_
9	responds	_	VBZ	_	_	4	NMOD	_	_
10	to	_	TO	_	_	9	VMOD	_	_
11	extrinsic	_	JJ	_	_	12	NMOD	_	_
12	signals	_	NNS	_	_	10	PMOD	_	_
13	,	_	,	_	_	9	P	_	_
14	reflecting	_	VBG	_	_	9	VMOD	_	_
15	increased	_	VBN	_	_	16	NMOD	_	_
16	inflammation	_	NN	_	_	14	VMOD	_	_
17	in	_	IN	_	_	16	NMOD	_	_
18	the	_	DT	_	_	19	NMOD	_	_
19	tissue	_	NN	_	_	17	PMOD	_	_
20	,	_	,	_	_	2	P	_	_
21	to	_	TO	_	_	2	VMOD	_	_
22	tightly	_	RB	_	_	21	VMOD	_	_
23	regulate	_	VB	_	_	21	IM	_	_
24	the	_	DT	_	_	25	NMOD	_	_
25	production	_	NN	_	_	23	VMOD	_	_
26	of	_	IN	_	_	25	NMOD	_	_
27	IL-10	_	NN	_	_	26	PMOD	_	_
28	so	_	RB	_	_	30	VMOD	_	_
29	as	_	RB	_	_	28	AMOD	_	_
30	to	_	TO	_	_	25	NMOD	_	_
31	allow	_	VB	_	_	30	IM	_	_
32	a	_	DT	_	_	34	NMOD	_	_
33	protective	_	JJ	_	_	34	NMOD	_	_
34	response	_	NN	_	_	31	VMOD	_	_
35	to	_	TO	_	_	31	VMOD	_	_
36	eradicate	_	VB	_	_	35	IM	_	_
37	a	_	DT	_	_	38	NMOD	_	_
38	pathogen	_	NN	_	_	36	VMOD	_	_
39	with	_	IN	_	_	38	NMOD	_	_
40	minimal	_	JJ	_	_	41	NMOD	_	_
41	damage	_	NN	_	_	39	PMOD	_	_
42	to	_	TO	_	_	41	NMOD	_	_
43	the	_	DT	_	_	44	NMOD	_	_
44	host	_	NN	_	_	42	PMOD	_	_
45	and	_	CC	_	_	36	COORD	_	_
46	also	_	RB	_	_	36	VMOD	_	_
47	prevent	_	VB	_	_	45	CONJ	_	_
48	chronic	_	JJ	_	_	49	NMOD	_	_
49	infection	_	NN	_	_	47	VMOD	_	_
50	.	_	.	_	_	2	P	_	_
		
1	Moreover	_	RB	_	_	5	VMOD	_	_
2	,	_	,	_	_	5	P	_	_
3	our	_	PRP$	_	_	4	NMOD	_	_
4	findings	_	NNS	_	_	5	VMOD	_	_
5	have	_	VBP	_	_	0	ROOT	_	_
6	important	_	JJ	_	_	7	NMOD	_	_
7	implications	_	NNS	_	_	5	VMOD	_	_
8	for	_	IN	_	_	7	NMOD	_	_
9	the	_	DT	_	_	10	NMOD	_	_
10	regulation	_	NN	_	_	8	PMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	IL-10	_	NN	_	_	13	NMOD	_	_
13	production	_	NN	_	_	11	PMOD	_	_
14	during	_	IN	_	_	5	VMOD	_	_
15	an	_	DT	_	_	18	NMOD	_	_
16	inflammatory	_	JJ	_	_	18	NMOD	_	_
17	Th1	_	NN	_	_	18	NMOD	_	_
18	response	_	NN	_	_	14	PMOD	_	_
19	in	_	IN	_	_	18	NMOD	_	_
20	infection	_	NN	_	_	19	PMOD	_	_
21	and	_	CC	_	_	5	COORD	_	_
22	may	_	MD	_	_	21	CONJ	_	_
23	be	_	VB	_	_	22	VC	_	_
24	of	_	IN	_	_	23	VMOD	_	_
25	relevance	_	NN	_	_	24	PMOD	_	_
26	for	_	IN	_	_	23	VMOD	_	_
27	the	_	DT	_	_	28	NMOD	_	_
28	design	_	NN	_	_	26	PMOD	_	_
29	of	_	IN	_	_	28	NMOD	_	_
30	vaccines	_	NNS	_	_	29	PMOD	_	_
31	and	_	CC	_	_	26	COORD	_	_
32	for	_	IN	_	_	31	CONJ	_	_
33	strategies	_	NNS	_	_	32	PMOD	_	_
34	in	_	IN	_	_	33	NMOD	_	_
35	immunotherapy	_	NN	_	_	34	PMOD	_	_
36	in	_	IN	_	_	35	NMOD	_	_
37	infectious	_	JJ	_	_	38	NMOD	_	_
38	diseases	_	NNS	_	_	36	PMOD	_	_
39	.	_	.	_	_	5	P	_	_
		
